A Review on Nanobots- A New Hope for Cancer Patients

Nanobots are emerging as a transformative technology in cancer therapy, offering innovative strategies for targeted treatment and enhanced drug delivery. These nanoscale robots can be engineered to navigate the complex tumor microenvironment, allowing for precise targeting of cancer cells while minimizing damage to healthy tissues. Utilizing various materials, such as lipids, polymers, and DNA, nanobots can be designed to perform specific functions, including drug release, imaging, and real-time monitoring of tumor dynamics. One of the key advantages of nanobots is their ability to deliver chemotherapeutic agents directly to tumor sites, improving drug efficacy and reducing systemic side effects. Additionally, they can be programmed to respond to specific biochemical signals, ensuring that therapeutic interventions are activated only in the presence of cancerous cells. This specificity enhances treatment outcomes and paves the way for personalized medicine approaches.Preclinical studies have demonstrated the potential of nanobots to improve therapeutic efficacy, enhance imaging capabilities, and facilitate combination therapies. However, challenges such as biocompatibility, toxicity, and the development of effective delivery systems remain to be addressed. Continued research and development in this field hold promise for the future of cancer therapy, potentially leading to more effective, less invasive treatment options.